普尼卡拉通过通过CX3CL1/CX3CR1轴抑制神经炎症来改善糖尿病认知功能障碍
Rou Zhang1, Xiuying Tan1, Yuhan Zhang1
1Xiangya School of Public Health, Central South University, Changsha, China.
Phytotherapy research : PTR
|November 27, 2025
概括
普尼卡拉金是一种天然化合物,通过减少神经炎症来治疗糖尿病认知功能障碍,显示出有前途. 它通过激活CX3CL1/CX3CR1通路来起作用,改善2型糖尿病中大脑功能.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病认知功能障碍是2型糖尿病 (T2DM) 的严重并发症,缺乏有效的治疗方法.
- 尼卡拉是一种多,具有神经保护性质.
- 神经炎症在糖尿病认知功能障碍中起着关键作用.
研究的目的:
- 研究punicalagin在改善糖尿病认知功能障碍中的机制.
- 为了确定punicalagin的作用是否通过抑制神经炎症进行介导.
- 探索CX3CL1/CX3CR1轴和Nrf2/HO-1通路的作用.
主要方法:
- 建立了T2DM的体内 (高脂肪饮食+链毒素) 和体内 (高血糖条件) 模型.
- 用punicalagin治疗糖尿病小鼠和高血糖细胞.
- 使用莫里斯水迷宫测试评估认知功能.
- 通过西方涂抹,免疫光和共同培养系统研究了分子机制.
主要成果:
- 普尼卡拉金降低了血糖,改善了学习和记忆,并在糖尿病小鼠中减少了神经炎症.
- 普尼卡拉对CX3CL1/CX3CR1轴和Nrf2/HO-1通路进行了上调.
- 对CX3CL1/CX3CR1轴的抑制降低了布尼卡拉在BV2细胞中的抗神经炎症作用.
结论:
- 普尼卡拉通过减少神经炎症来改善T2DM中的认知功能障碍和神经元损伤.
- 激活CX3CL1/CX3CR1信号通路是一个关键机制.
- 普尼卡拉代表了糖尿病认知功能障碍的潜在治疗策略.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
517
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
517
Psychoneuroimmunology: Diabetes and Cancer
412
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
412
Dipeptidyl Peptidase 4 Inhibitors
559
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
559


